CL
47
-3
AMT
38
2
RL
80
-3
EXPD
27
-2
AIG
60
3
KMI
71
2
FMC
30
-3
FE
64
-2
MLM
53
-4
NAVI
46
6
GRMN
52
2
SLG
56
4
A
47
-4
PLD
46
5
APD
42
2
GT
45
-2
MSI
44
-3
EOG
45
3
BXP
41
3
WDC
61
-2
CL
47
-3
AMT
38
2
RL
80
-3
EXPD
27
-2
AIG
60
3
KMI
71
2
FMC
30
-3
FE
64
-2
MLM
53
-4
NAVI
46
6
GRMN
52
2
SLG
56
4
A
47
-4
PLD
46
5
APD
42
2
GT
45
-2
MSI
44
-3
EOG
45
3
BXP
41
3
WDC
61
-2
Financhill
Back

Aldeyra Therapeutics 10K Form

Sell
27

ALDX
Aldeyra Therapeutics

Last Price:
$2.20
Seasonality Move:
20.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ALDX News And Ratings

See the #1 stock for the next 7 days that we like better than ALDX

ALDX Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-12M
Price / Cash Flow: 0
Annual Sales: $1.19
Price / Book: 1.83

Profitability

EPS (TTM): -0.94000
Net Income (TTM): $-55.9M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Aldeyra Therapeutics Earnings Forecast

Key Aldeyra Therapeutics Financial Ratios

  • Per Share Earnings over the last 14 years have been positive in 8 years.

Aldeyra Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALDX
CUSIP: 01438T
Website: aldeyra.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 7.52

ALDX Technical Analysis vs Fundamental Analysis

Sell
27
Aldeyra Therapeutics (ALDX) is a Sell

Is Aldeyra Therapeutics a Buy or a Sell?